| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |